[1]
Ding, B. et al. 2023. Combined application of dupilumab and mite allergen-specific immunotherapy in children with moderate to severe atopic dermatitis. Allergologia et Immunopathologia. 51, 2 (Mar. 2023), 184–190. DOI:https://doi.org/10.15586/aei.v51i2.778.